TNFalpha-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3

Kazuya Kabayama1, Takashige Sato, Futoshi Kitamura

  • 1Department of Biomembrane and Biofunctional Chemistry, Graduate School of Pharmaceutical Sciences, Frontier Research Center for Post-Genomic Science and Technology, Hokkaido University, Kita 21-Nishi 11, Kita-ku, Sapporo 001-0021, Japan.

Glycobiology
|August 13, 2004
PubMed

Insights

Tumor necrosis factor alpha (TNFα) causes insulin resistance by increasing ganglioside GM3 in membrane microdomains. This disrupts insulin receptor signaling, leading to a loss of insulin receptors in these critical cellular compartments.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Metabolic Diseases

Background:

  • Membrane microdomains (lipid rafts) are crucial for insulin signaling compartmentalization.
  • The role of microdomains in insulin resistance pathogenesis is largely unexplored.
  • Tumor necrosis factor alpha (TNFα) is implicated in type 2 diabetes and insulin resistance.

Purpose of the Study:

  • To investigate the role of membrane microdomains in TNFα-induced insulin resistance.
  • To determine the specific function of ganglioside GM3 in this process.

Main Methods:

  • Isolation of detergent-resistant membrane microdomains (DRMs) from 3T3-L1 adipocytes.
  • Quantification of ganglioside GM3 and insulin receptor (IR) levels in DRMs.
  • Assessment of IR internalization and IR-IRS-1 signaling.

Main Results:

  • TNFα treatment significantly increased GM3 levels in DRMs.
  • IR accumulation in DRMs was reduced in TNFα-treated cells.
  • Insulin-dependent IR internalization and IR-IRS-1 signaling were suppressed.
  • GM3 depletion reversed TNFα-induced inhibition of IR internalization and DRM accumulation.

Conclusions:

  • Increased GM3 in membrane microdomains contributes to insulin resistance by reducing IRs in these compartments.
  • GM3 accumulation disrupts insulin receptor signaling, leading to impaired insulin action.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...